Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial

This publication has 21 references indexed in Scilit:

• The public health impact of chloroquine resistance in Africa
  The American Journal of Tropical Medicine and Hygiene, 2001
• Molecular Evidence of Greater Selective Pressure for Drug Resistance Exerted by the Long‐Acting Antifolate Pyrimethamine/Sulfadoxine Compared with the Shorter‐Acting Chlorproguanil/Dapsone on KenyanPlasmodium falciparum
  The Journal of Infectious Diseases, 2000
• Chemotherapy for Falciparum Malaria: The Armoury, the Problems and the Prospects
  Parasitology Today, 2000
• Cost-effectiveness of malaria control in sub-Saharan Africa
  The Lancet, 1999
• Kenyan Plasmodium falciparum Field Isolates: Correlation between Pyrimethamine and Chlorcycloguanil Activity In Vitro and Point Mutations in the Dihydrofolate Reductase Domain
  Antimicrobial Agents and Chemotherapy, 1998
• Mutations inPlasmodium falciparumDihydrofolate Reductase and Dihydropteroate Synthase and Epidemiologic Patterns of Pyrimethamine‐Sulfadoxine Use and Resistance
  The Journal of Infectious Diseases, 1997
• The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses
  Parasitology Today, 1997
• Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993
• Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
  Proceedings of the National Academy of Sciences, 1990
• Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine
  Gene, 1989